Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Essential Amino Acid Supplementation in Older Adult COVID-19 Patients
NCT04816071Phase 3Withdrawn
- Sponsor
- University of Arkansas
- Start
- May 2021
- Primary completion
- May 2021
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) (4 arms), sponsored by University of Arkansas. Primary endpoint: Improvement in symptoms at 12 weeks. Planned start May 2021; status: withdrawn.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04816071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04816071.